President & Co-Founder
Current• Founding team member of start-up clinical stage pharma company that is re-purposing hydroxychloroquine (HCQ) as first-in-class, non-hormonal therapy for endometriosis.• Supervising IP strategy, including one issued and multiple pending patents• Leading regulatory initiative to move company forward with FDA through a Pre-IND meeting, definition & execution of a clinical trial, submission of results and approval of a new endo indication for HCQ• Coordinating advisors, including clinicians (rheumatologists w/ HCQ experience and OB/GYNs w/ endo expertise) and patient advocacy groups (PAGs)• Developed business plan and leading financing effort• Managing the product sourcing strategy